Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs) are rare tumors comprising of both adenocarcinoma and neuroendocrine component, at least 30% of each in the lesion.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Pande P
Authors: Pande P, Desai G, Shah R, Palepu J,
Keywords: minen, biliary mixed neuroendocrine-nonneuroendocrine neoplasms,
Introduction: FOLFOX has been poorly investigated in digestive NEN (DNENs), mostly in small cohorts.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Dal Buono A, Merola E, Delle Fave G, Wiedenmann B, Pavel M,
Keywords: FOLFOX, tolerability, tumor response.,
#1537 Antitumor Efficacy of Temozolomide in Patients with Metastatic Pulmonary Carcinoids
Introduction: Temodal (TMZ) is an oral alternative to dacarbazine.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Bello Roufai D, Planchard D, Walter T, Berdelou A, Guigay J,
Keywords: pulmonary carcinoids, temozolomide, safety,
#1387 FOLFOX in Neuroendocrine Tumors
Introduction: Favorable toxicity profile and significant antitumor activity of FU-oxaliplatin in several malignancies led us to evaluate FOLFOX in advanced neuroendocrine carcinomas (NETs).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Faure M
Authors: Faure M, Raoul J, Autret A, Mineur L, Boustany R,
Keywords: Neuroendocrine tumors, folfox, clinical improvement, break in treatment, PFS, OS,
Introduction: Oxaliplatine plus fluoropirimidine and capecitabine treatment alone are considered investigational treatments in well-differentiated (WD) NET
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Marconcini R
Authors: Marconcini R, Ricci S, Galli L, Antonuzzo A, Vasile E,
Keywords: capecitabine, oxaliplatine ,